Slingshot members are tracking this event:

Phase 2/3 data of BMN-701 (reveglucosidase alfa) for Pompe Disease presented at the 20th International Congress of the World Muscle Society

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 04, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pompe Disease, Bmn-701, Reveglucosidase Alfa